Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: The Children's Cancer Group (CCG) experience - Concepedia

Concepedia

Publication | Closed Access

Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: The Children's Cancer Group (CCG) experience

126

Citations

39

References

2004

Year

Patrick Van Winkle, Anne Angiolillo, Mark Krailo, Ying‐Kuen Cheung, Barry Anderson, Virginia Davenport, Gregory H. Reaman, Mitchell S. Cairo

Pediatric Blood & Cancer

Abstract

The ORR to ICE reinduction chemotherapy in children with recurrent/refractory sarcoma was 51%. OS of 1 and 2 years appeared significantly improved in patients who had CR or PR following ICE reinduction therapy or who had rhabdomyosarcoma with embryonal histology.

References

	Year	Citations

Page 1